Furthermore, FABP4 serum and adipose tissue level could be modulated by obesity; hence, we analyzed patients with central obesity and potential metabolic complications separately from non-obese patients. This evidence concerns the gene FABP4 and obesity due to melanocortin 4 receptor deficiency.